MétaCan
Menu
Back to cohort

Cancer-related cognitive dysfunction (CRCD) and psychosocial development in young adult cancer survivors.

2015· article· en· W2612597991 on OpenAlexaff
Kim Edelstein, Norma Mammone D’Agostino, Gregory R. Pond, Sylvie Aubin, Andrew Matthew, Kate Wahl, Abha A. Gupta, Petr Kavan, Michael Crump, Philippe L. Bédard, Andre C. Schuh, David Hodgson, T. Vuong, Thierry Muanza, Gerald Batist, Lori J. Bernstein

Bibliographic record

VenueJournal of Clinical Oncology · 2015
Typearticle
Languageen
FieldMedicine
TopicCancer-related cognitive impairment studies
Canadian institutionsJewish General HospitalOntario Clinical Oncology GroupPrincess Margaret Cancer CentreMcGill UniversityUniversity Health Network
Fundersnot available
KeywordsMedicinePsychosocialNeurocognitiveCancerProspective cohort studyBreast cancerGeriatric oncologyCohortInternal medicineOncologyCognitionPsychiatry

Abstract

fetched live from OpenAlex

TPS9636 Background: Chemotherapy is associated with long-lasting neurocognitive sequelae and structural and functional brain imaging changes in about 25% of older adults who do not receive central nervous system (CNS) directed treatment. This suggests that cancer or its treatment affects the brain regardless of primary tumor site. Because the brain continues to develop into the 3rd decade of life, younger adults (YA; age 18-39 yrs) may be vulnerable to CRCD. Cancer also disrupts acquisition of developmental milestones in YA. CRCD may exacerbate those disruptions, but this has never been studied. Study aims are to characterize CRCD in YA, explore its relation to psychosocial development, and identify subgroups at risk of adverse outcomes. Methods: In this prospective, inception-cohort study, we are recruiting YA who do not require CNS-directed therapy from ambulatory clinics at the Princess Margaret Cancer Centre (leukemia, lymphoma, breast, gynecology, gastrointestinal, genitourinary, sarcoma) and the YA Oncology clinic at the Jewish General Hospital: 200 YA with cancer who require chemotherapy, 100 YA with cancer who do not require it, and 100 healthy YA with no cancer history. As of Jan 30 2015, 113 participants were enrolled. Chemotherapy patients are assessed prior to treatment, and then 6 and 12 months later. The other groups are assessed at similar time intervals. The 2-hr test battery consists of standardized neurocognitive tests sensitive to CRCD and validated self-report psychosocial measures. Repeated measures mixed effects models will be used to examine longitudinal changes in each of the neurocognitive domains and each of the psychosocial development scores, using the predicted residual sum of squares method to avoid interpretation problems associated with repeated testing. Relationships between CRCD, psychosocial development, treatment, cancer type, and individual characteristics will be examined using regression. Exploratory analyses will investigate whether demographic, disease, or treatment factors contribute to longitudinal changes. Results will provide the basis for interventions that alleviate the psychosocial and cognitive sequelae in this underserved population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.014
Threshold uncertainty score0.028

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.113
GPT teacher head0.469
Teacher spread0.355 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicCancer-related cognitive impairment studiesFrench-language works237,207